GAIA
About GAIA
GAIA develops evidence-based, safe and accessible digital therapeutics to help patients restore and maintain mental and physical health. The company combines science, technology and therapy with over 20 years of experience and a broad product portfolio focused on clinically validated digital health solutions.
GAIA operates multidisciplinary teams of physicians, psychotherapists, clinical scientists, software engineers, regulatory and market-access specialists to design, test and bring top-tier digital therapeutics to major markets.
- Over 20 years of experience
- More than 70 products
- Clinically proven effectiveness in multiple randomized controlled trials and meta-analyses
Products & Expertise
Key areas include development and clinical validation of digital therapeutics (DTx), conducting Phase II & III trials, and ensuring regulatory and market access readiness. One of GAIA’s most-researched products is deprexis®, an online program for depression that has been evaluated in numerous RCTs with effect sizes comparable to antidepressants in clinical settings.
Headquarters and contact details listed publicly include an office in Hamburg, Germany and GAIA America Inc in New York, NY. General contact: [email protected]; Phone: +49 40 3510520.
